Although new therapeutic strategies such as hematopoietic stem cell transplantation or anti CCR4 antibodies are now being developed to treat ATLL, the overall prognosis of ATLL patients remains very poor1. This evidence concerns the gene CCR4 and adult T-cell leukemia/lymphoma.